Pfizer Inc.
Pfizer Inc. (NYSE: PFE) is a $165.8B drug manufacturers - general company trading at $29.02 — 21.3× trailing earnings, yielding 5.90%. Figures from SEC EDGAR and market feeds; updated 2026-09-03 10:20 UTC.
Pfizer Inc. (NYSE: PFE) is a $165.8B drug manufacturers - general company trading at $29.02 — 21.3× trailing earnings, yielding 5.90%. Figures from SEC EDGAR and market feeds; updated 2026-09-03 10:20 UTC.
| Quote | |
| Price | $29.02 |
| Market cap | $165.8B |
| Volume | 39.23M shares |
| 52-week range | $23.62 – $29.09 |
| Valuation | |
| P/E (TTM) | 21.34× |
| EPS (TTM) | $1.36 |
| Dividend yield | 5.90% |
| Price/book | 1.92× |
| Return on equity | 8.99% |
| Debt/equity | 0.75 |
| Returns | |
| 52-week return | +22.9% |
Pfizer Inc. is a drug manufacturers - general company, listed on NYSE as PFE.
PFE trades at $29.02, 21.34× trailing earnings, as of 2026-09-03. It carries a 5.90% dividend yield.
Pfizer Inc.'s most recent SEC filing on record is a 10-Q filed 2026-08-04. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-09-03 10:20 UTC. This page is also available as JSON at /api/data?ticker=PFE and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for PFE and 5,000+ tickers.
Create a free account — keep PFEGET /api/data?ticker=PFE
This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt